Trident Texofab Intrinsic Value
TTFL • Textiles
Current Stock Price
₹47.69
Primary Intrinsic Value
₹28.80
Market Cap
₹66.8 Cr
-29.6%
Downside
Median Value
₹33.57
Value Range
₹20 - ₹71
Assessment
Trading Above Calculated Value
Safety Margin
-42.1%
TTFL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹28.80 | ₹23.04 - ₹34.56 | -39.6% | EPS: ₹2.40, Sector P/E: 12x |
| Book Value Method | asset | ₹33.57 | ₹30.21 - ₹36.93 | -29.6% | Book Value/Share: ₹33.57, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹70.86 | ₹63.77 - ₹77.95 | +48.6% | Revenue/Share: ₹88.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹38.57 | ₹34.71 - ₹42.43 | -19.1% | EBITDA: ₹9.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹28.54 | ₹22.83 - ₹34.25 | -40.2% | CF Growth: 14.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹38.40 | ₹34.56 - ₹42.24 | -19.5% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹20.15 | ₹18.13 - ₹22.16 | -57.7% | Revenue Growth: 9.9%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹23.84 | ₹21.46 - ₹26.22 | -50.0% | ROE: 6.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹42.58 | ₹38.32 - ₹46.84 | -10.7% | EPS: ₹2.40, BVPS: ₹33.57 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
TTFL Intrinsic Value Analysis
What is the intrinsic value of TTFL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Trident Texofab (TTFL) is ₹33.57 (median value). With the current market price of ₹47.69, this represents a -29.6% variance from our estimated fair value.
The valuation range spans from ₹20.15 to ₹70.86, indicating ₹20.15 - ₹70.86.
Is TTFL undervalued or overvalued?
Based on our multi-method analysis, Trident Texofab (TTFL) appears to be trading above calculated value by approximately 29.6%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.69 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 6.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.23x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Trident Texofab
Additional stock information and data for TTFL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-14 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹2 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |